Literature DB >> 4004626

Thrombin infusion for the control of intraocular bleeding during vitreous surgery.

S de Bustros, B M Glaser, M A Johnson.   

Abstract

Intraocular bleeding is often a major problem during vitrectomy for proliferative diabetic retinopathy and trauma. We have studied the effect of thrombin on the control of intraocular bleeding during vitreous surgery in rabbit eyes. Thrombin (100 units/mL) infusion solution reduced the bleeding time by more than fivefold. Toxicity studies showed no adverse effect on the lens and corneal endothelium. Electroretinogram b-wave amplitudes were normal, but electroretinogram sensitivity was reduced by 0.5 log units in experimental eyes. Thrombin appears to be a potential agent for the control of intraocular bleeding during vitreous surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004626     DOI: 10.1001/archopht.1985.01050060097034

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  The role of topical thrombin in skin grafting.

Authors:  F A Ofodile; M K Sadana
Journal:  J Natl Med Assoc       Date:  1991-05       Impact factor: 1.798

2.  Thrombin stimulates the proliferation of human retinal glial cells.

Authors:  D G Puro; T Mano; C C Chan; M Fukuda; H Shimada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors:  Ashraf M El-Batarny
Journal:  Clin Ophthalmol       Date:  2008-12

Review 4.  Vitreous Substitutes as Drug Release Systems.

Authors:  André Schulz; Peter Szurman
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

Review 5.  Vitreous substitutes: the present and the future.

Authors:  Simone Donati; Simona Maria Caprani; Giulia Airaghi; Riccardo Vinciguerra; Luigi Bartalena; Francesco Testa; Cesare Mariotti; Giovanni Porta; Francesca Simonelli; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.